Effectiveness of 5% fluorouracil ointment in the treatment of genital warts
Phase 2
Recruiting
- Conditions
- Genital wart.Viral warts
- Registration Number
- IRCT20230913059421N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who are diagnosed with genital warts for the first time or who have not received treatment for genital warts in the last three months.
Do not have any other skin disease
Exclusion Criteria
Patients with immune system dysfunction
Having a previous history of allergy to the studied drugs
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocation of the lesion. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;The size of the lesion. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;Number of genital warts. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method Recurrence of the disease. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;Side effects. Timepoint: 1 and 3 months after treatment. Method of measurement: Physical examination.